Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism.

Cells - 18 May 2020

Lefort Charlotte, Roumain Martin, Van Hul Matthias, Rastelli Marialetizia, Manco Rita, Leclercq Isabelle, Delzenne Nathalie M, Marzo Vincenzo Di, Flamand Nicolas, Luquet Serge, Silvestri Cristoforo, Muccioli Giulio G, Cani Patrice D

Abstract excerpt

Diverse metabolic disorders have been associated with an alteration of N-acylethanolamine (NAE) levels. These bioactive lipids are synthesized mainly by N-acylphosphatidylethanolamine-selective phospholipase D (NAPE-PLD) and influence host metabolism. We have previously discovered that NAPE-PLD in the intestine and adipose tissue is connected to the pathophysiology of obesity. However, the physiological function...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet, High-Fat
Share to Hepatocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Lipid Metabolism

Share to Mice, Obese

Share to Organ Specificity

Share to Phospholipase D

Source

Open in PubMed Open full text

Identifiers

PMID: 32443626
DOI: 10.3390/cells9051247
PMCID: PMC7291298

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism.PMID 32443626Read ↗

MTARC1 Regulates Lipid Droplet Degradation via Phospholipid Remodeling in Metabolic Fatty Liver DiseaseSemantic proximity Read ↗

Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.Semantic proximity Read ↗

Substrate-Specific Function of PNPLA3 Facilitates Hepatic VLDL-Triglyceride Secretion During Stimulated LipogenesisSemantic proximity Read ↗

Loss of Carnitine Palmitoyltransferase 1a Reduces Docosahexaenoic Acid-Containing Phospholipids and Drives Sexually Dimorphic Liver Disease in MiceSemantic proximity Read ↗

Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.Semantic proximity Read ↗

Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice.Semantic proximity Read ↗

Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in miceSemantic proximity Read ↗

Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor−/− Mice Improves Indices of Cardiometabolic DiseaseSemantic proximity Read ↗

Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.Semantic proximity Read ↗

Experimental Models to Investigate PNPLA3 in Liver Steatosis.Semantic proximity Read ↗

Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets.Semantic proximity Read ↗

The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.